Zansecimab

CAT: 0804-HY-P99510-01Size: 1 mgDry Ice: YesHazardous: No
CAT#:0804-HY-P99510-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Zansecimab (LY-3127804) is an immunoglobulin G4-kappa, a monoclonal antibody against angiopoietin 2 (Ang 2) . Zansecimab has potential applications in angiogenesis and immune regulation[1][2][3].
CAS Number
[2415205-37-5]
Product Name Alternative
LY-3127804
UNSPSC
12352203
Target
Tie
Type
Inhibitory Antibodies
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/zansecimab.html
Purity
95.0
Solubility
10 mM in DMSO
Smiles
[Zansecimab]
Molecular Weight
(145.24 kDa)
References & Citations
[1]Yen CC, et al. Safety of ramucirumab treatment in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein. Expert Opin Drug Saf. 2022 Feb;21 (2) :157-166.|[2]Wang Y, et al. Angiogenesis as a potential treatment strategy for rheumatoid arthritis. Eur J Pharmacol. 2021 Nov 5;910:174500.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
592326Zansecimab
E55B0816Zansecimab (Reference antibody)
MBS1563263-01Research Grade Zansecimab
C00537-01Zansecimab (Anti-ANGPT2)
047876ANGPT2 (zansecimab) discontinued
ICH5290-10mgZansecimab Biosimilar - Research Grade
21-993Zansecimab - Research Grade Biosimilar
F2082-.1Anti-ANGPT2 Antibody (Zansecimab)
M00370-3Anti-ANGPT2 Reference Antibody (zansecimab)
BIO0422SM-5mgAnti-human ANGPT2 (Zansecimab Biosimilar)

Popular Products